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Summary.-In a controlled experiment, 6 groups of SPF rats were given cigarette
smoke condensate (SWS) in solid form without a vehicle once fortnightly by intra-
tracheal instillation, at 3 dose levels with or without additional exposure to the
vapour phase of smoke (VP) from 10 plain cigarettes each week. Treatment continued
for life. Six other groups were similarly treated with one of 3 fractions of condensate
with or without VP.
Exposure to VP was associated with a significant reduction in body weight, but
not significantly with the incidence or severity of any observed pathological change
in the lungs.
A significant dose-related association was seen between SWS or its fractions and
the incidence and degree of chronic respiratory disease (CRD), cuboidal or columnar
metaplasia (CCM) and squamous metaplasia ofalveolar,epithelium (Sq.M) produced.
No neoplasms, however, were elicited. A significant correlation was found between
the degrees of CCM and of Sq.M produced in the 24 groups exposed to SWS or frac-
tions.
The results are discussed in the light of studies in which rats were exposed to
tobacco smoke byinhalationand ofstudies inwhichthe same condensate and fractions
were applied to mouse skin.
THIS STUDY describes the effects of
exposure to the vapour phase (VP) of
cigarette smoke on the lungs of rats and
was designed to see whether exposure to
VP alters the response of rat lung to the
intratracheal instillationofcigarettesmoke
condensate or its fractions.
MATERIALS AND METHODS
Rats.-A total of 360 female non-inbred
Wistar specified pathogen-free rats were
obtained from Scientific Products Limited.
They were allocated by a non-selective
process to 28 groups as shown in Table I.
They were aged 13-14 weeks at the start of
the experiment. Details of diet, caging and
periodic treatment with tetracycline to
counter nonspecific respiratory disease are
given in a parallel paper (Davis et al., 1975b).
Preparation of cigarette smoke condensate
(SWS) and its fractions.-Details of the
method of preparation of SWS and of
fractions G, (R + P)G and PtSG) are
described in Davis et al. (1975a).
Exposure to vapour phase (VP) ofcigarette
smoke.-Rats were exposed to VP in an
apparatus known as the " Harrogate
Smoker ". This has been fully described
elsewhere by Davis, Houseman and Roderick
(1973).
For the experiment reported here, the
apparatus was adjusted to take one puff of
25 ml vol and 2 sec duration regularly once
every min. The smoke was passed through a
Cambridge filter so that only the Vapour
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Phase (VP) of the smoke (25 ml) was drawn
into the chamber containing 100 ml air,
where it was held as a 1 in 5 mixture ofVP in
air for a period of 15 sec. Rats were fitted
snugly into perspex tubes such that their
noses protruded into the chamber. When in
position, rats were offered fresh air to breathe
during 45 sec and the 1 in 5 VP in air
mixture during the remaining 15 sec of each
min of exposure. Rats were thus exposed to
VP from one cigarette twice each day, once
in the morning and once in the afternoon, on
5 days ofeach week. On average, 11 puffs of
25 ml were taken from each cigarette and the
unsmoked butt after 11 puffs taken under the
conditions described averaged 20 mm in
length.
Other details.-The technique of intra-
tracheal instillation, details of observations
made during experiments, post-mortem pro-
cedure, microscopic examination of tissues
and statistical methods are described by
Davis et al. (1975b).
RESULTS
The essential design of the experiment
is depicted in Table I. Rats were given
SWS or one of 3 different fractions
derived from it, by intratracheal instilla-
tion, fortnightly from the age of 13-14
weeks until death. Groups of 12 rats
were treated thus at 3 different dose levels
and, in addition, were exposed to the
vapour phase (VP) of the smoke from 10
Groups
1, 2, 3
4, 5, 6
7, 8, 9
10, 11, 12
13, 14, 15
16, 17, 18
19, 20, 21
22, 23, 24
Controls
25
26
27
28
cigarettes each week. Comparable groups
were treated similarly with condensate or
fractions but were not exposed to VP. A
control group of 18 rats was left untreated
(Group 28). A second control group (18
rats) was exposed to VP only (Group 27).
A third control group (18 rats) was given
a dose of atropine and was anaesthetized
with ether once fortnightly as for treat-
ment by intratracheal instillation but was
given no treatment via the trachea
(Group 25). A fourth control group (18
rats) was treated similarly to Group 25 and
exposed to VP (10 cigarettes per week) in
addition (Group 26).
Survival
Table I summarizes the results in
respect of survival.
Rats exposed to VP twice daily (on
5 days per week) (Group 27) showed a
slightly lower survival rate than either
untreated control rats (Group 28) or rats
that were anaesthetized fortnightly and
put in a tube twice daily but not actually
exposed to VP (Group 26). (Mean
survival times were 100, 114 and 111
weeks respectively.)
With only one exception out of 24,
fraction G given with VP at the lowest
dose level (Group 10), the intratracheal
instillation of SWS or its fractions, with
TABLE I.- Details of Treatment and Survival
Mean survival from start of
Treatment-condensate
or fraction (given
once-fortnightly by
intratracheal 1(
instillation)
SwS
swS
Fraction G
Fraction G
Fraction P(SG)
Fraction P(SG)
Fraction (R+P)G
Fraction (R+P)G
Dose given
each Equivalent
treatment dose of
low dose level condensate
(mg) (mg)
11 11
11 11
11 44
11 44
7.5 417
7-5 417
12 364
12 364
Vapour
ph*se
(x 10
weekly)
0
+
0
+
0
0 ±
treatment (weeks)
A
Medium High
dose dose
Low dose (low x 2) (low x 4)
89 71 20
88 39 27
102 93 72
105 65 57
87 88 59
82 66 50
104 77 64
93 94 64
Atropine and anaesthetic once fortnightly
Atropine and anaesthetic once fortnightly and sham exposed to VP x 10 weekly
Vapour phase x 10 weekly
None
Mean
survival
106
111
100
114
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or without VP, reduced survival time as
compared with the relevant control group.
In the case of each of the 8 sets of 3 dose
levels there was a clear relationship
between dose ofcondensate or fraction and
survival.
In general, rats treated with SWS or
one of its fractions and exposed to VP
showed a slightly lower survival rate than
the corresponding group not exposed to
VP.
Effect ofexposure to VP and other treatment
on body weight
Twice daily exposure to VP consis-
tently reduced body weight gain, irres-
pective of whether rats received other
treatment. At 24 weeks and thereafter
the mean body weight of rats exposed to
VP twice daily was 40-70 g less than that
of untreated rats of the same age, and the
mean body weight of rats exposed to VP
and to intratracheal instillation was 25-
50 g less than that of rats exposed to
intratracheal instillation only.
The effects of exposure to VP became
apparent during the first 4 weeks of
exposure. A statistical analysis showed
that during the period in question intra-
tracheal instillation of any of the 3
fractions alone caused no reduction in
body weight, whereas treatment with
SWS did reduce body weight, and that
VP caused a general reduction in body
weight except in the already reduced
SWS groups.
Effect of exposure to VP and other treat-
ments on incidence of chronic respiratory
diseases (CRD) (Table II)
The mean grades of CRD observed
were compared with those expected on the
basis of the incidence of the disease in all
rats in the experiment that were examined
post mortem. The mean grades of CRD
observed in all 4 control groups were
lower than expected and this difference
was significant for the 2 control groups
exposed to AVP without treatment by
intratracheal instillation (Groups 26 and
27). A significantly lower mean grade
than expected was also seen in the 8
groups given low doses of SWS or its
fractions with or without VP (P < 0.01).
In contrast, significantly higher than
expected grades were seen in the 8 groups
given intermediate dosesofSWSoritsfrac-
tions a VP (P < 0 01) and in the 8 groups
given high doses of SWTS or its fractions
± VP (P < 0.01). In the groups that
received SWS or fractions by intratracheal
instillation, in general, exposure to VP
had little, if any, effect on mean grade or
CRD. The P(SG) fraction, however,
differed from the other 2 fractions and
from SWS itself, firstly in that at the inter-
mediate and high dose levels treatment
was associated with significantly higher
than expected mean grades of CRD and,
secondly, in that at the 2 higher dose
levels of the fraction the excess of ob-
served mean grade over expected was
more marked in VP exposed rats than
in rats not exposed to VP.
A comparison ofthe 12 groups exposed
to SWS or fraction-i+ VP with the 12
groups exposed to SWS or fraction
without VP revealed no evidence that
exposure to VP increased the incidence of
CRD.
Effect of exposure to VP and other treat-
ments on incidence ofcuboidal and columnar
metaplasia of alveolar epithelium (CCMI)
(Table II)
Table II also shows the observed and
expected mean grades of CCM. In each of
the 4 control groups, including the 2
exposed to VP (Groups 26 and 27),
significantly (P < 0.01) lower grades of
CCM were observed than expected on the
basis of the incidence of CCM in all the
rats in the experiment. When combined,
the 8 groups given intermediate doses of
SWS or fractions a VP and the 8 groups
given high doses of SWS or fractions
+ VP showed significantly (P < 0-01)
higher mean grades ofCCM than expected.
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TABLE II.-Effect ofTreatment on Incidence of ORD, CCM and Sq.M
Treatment by
Group intratrachealinstillation
I 11 mg SWS
2 22 mg SWS
3 44 mg SWS
4 11 mg SWS
5 22 mg SWS
6 44 mg SWS
All groups treated with SWS
7 11 mg Fraction G
8 22 mg Fraction G
9 44 mg Fraction G
10 11 mg Fraction G
11 22 mg Fraction G
12 44 mg Fraction G
All groups treated with
fraction G
13 7 -5 mg Fraction P(SG)
14 15 mg Fraction P(SG)
15 30 mg Fraction P(SG)
16 7 -5 mg Fraction P(SG)
17 15 mg Fraction P(SG)
18 30 mg Fraction P(SG)
All groups treated with
fraction P(SG)
19 12mg Fraction (R+P)G
20 24mg Fraction (R+P)G
21 48mg Fraction (R+P)G
22 12mg Fraction (R+P)G
23 24mg Fraction (R+P)G
24 48mg Fraction (R+P)G
All groups with fraction
(R+P)G
All groups not exposed to VP
All groups exposed to VP
All groups given low doses
of SWS or fractions
All groups given inter-
mediate doses of SWS or
fractions
All groups given high doses
of SWS or fractions
Controls
25 Atropine and
anaesthetic only
26 Atropine and
anaesthetic plus VP
27 VP only
28 None
No. of
rats
examined
With post- Mean grade of
i VP mortem CRD 0 (E)
0 11 2 - 27 (2*36)
0 11 2-55(2-41)
0 10 2-10 (2-44)
+ 12 2-08 (2-42)-
+ 11 2 55 (2 36)
+ 12 2-50 (2-33)
67 2 - 34 (2
-39)
0
0
0
±
+
+
0
0
0
+
+
0
0
0 ±
±
±
12
12
11
12
12
12
71
12
11
10
12
11
12
68
11
12
12
12
11
12
70
135
141
94
91
91
17
17
18
16
2 -08 (2-37)
2-42 (2-37)
2 -27 (2 -33)
2-25 (2 -36)
2 -50 (2-44)
2 - 75 (2-52)
2 - 38 (2-40)
2 -50 (2 -36)
2 - 82 (2-44)+
2 -90 (2 -52)+
2 -08 (2-38)
2 -91 (2 -39)++
3-00 (2 -38)++
2 -69 (2 -41)+++
2 -27 (2-30)
2-58 (2-49)
2-67 (2-43)
2-08 (2-32)
2 -55 (2-44)
2 -75 (2-46)
2-49 (2-41)
Mean grade of
CCM 0 (E)
0-55 (1-03)
0-55 (0-72)
0-00 (0-32)
0-50 (0-90)
0-55 (0-52)
0-33 (0-35)
0-42 (0-64)
1-00 (1-11)
1- 75 (1-11)
1-45 (0-86)
0-58 (1-16)
1-33 (0-72)
1-33 (0-78)
1-24 (0-96)+
1-17 (0-90)
1-27 (0 80)
1-50 (0-71)+
1 -08 (0-87)
0-91 (0-80)
0-42 (0-53)
1 -04 (0-77)+
1 -73 (1*68)
0 -92 (0 76)
1 -00 (0-67)
1-17 (1-08)
2-09 (0-90)...
1
- 75 (0-70)++
1 -43 (0-95)...
No. of rats
with Sq.M
O (E)
1 (1-9)
3 (1-8)
0 (1-5)
1 (2-3)
2 (1-6)
1 (1-7)
8 (10-8)
Mean grade
of Sq.M
0 (E)
0-18 (0.27)
0-45 (0-31)
0-00 (0-33)
0-08 (0 36)
0-36 (0
-30)
0-25 (0 32)
0-22 (0-32)
1 (2-4) 0-08 (0-32)
2 (2-1) 0-25 (0-29)
4 (1- 9) 0-55 (0- 31)
0 (2-4) 0-00 (0-32)
3 (1-8) 0-33 (0-28)
3 (2-1) 0-42 (0 32)
13 (12-7) 0-27 (0-31)
0 (2-0)
4 (2-0)
4 (1-7)+
1 (2-0)
1 (1-8)
4 (1-8)
14 (11-3)
2 (2-7)
2 (2-2)
3 (1-8)
2 (2-3)
7 (2 -2)+++
6 (2-0)++
22 (13-2)++
0-00 (0-30)
0-82 (0-34)
1 -00 (0*31)++
0-08 (0-31)
0-09 (0-31)
0-58 (0-31)
0-41 (0-31)
0-45 (0 36)
0-33 (0*33)
0-67 (O-30)
0-17 (0 32)
0-91 (0-36)+
1-08 (0-32)+++
0-60 (0-33)++
2-45 (2-40) 1-08 (0-90) 26 (24-0) 0-39 (0-31)
2-50 (2-40) 1-00 (0 78)+ 31 (24-0) 0-36 (0 32)
2-20 (2-36)-- 0-97 (1-09) 8(18-0)-- 0-13(0 32)-
2-60 (2-42)++ 1-18 (0 79)++ 24 (15-5)+ 0-44 (0 31)
2-63 (2-43)++ 0-98 (0-62)++ 25 (14-5)++ 0-57 (0-31)++
2-18 (2-39) 0-24 (1-13)-- 1 (3-4)
2-12 (2-40)- 0-29 (1 09)--
1-94 (2-39)--- 0-28 (1-08)--
2-13 (2-38) 0-31 ( 1-5)--
0 (3-6)-
3 (3-8)
1 (3-3)
0-06 (0-35)
0-00 (0-36)
0-28 (0-34)
0-06 (0-34)
The main contribution to this excess
came from rats in the groups given inter-
mediate or high doses of fraction (R + P)
G plus exposure to VP (Groups 23 and 24).
Treatment with fraction G at any
level VP (Groups 7-12 combined) or
with fraction P(SG) at any level ± VP
(Groups 13-18 combined) was associated
with significantly (P < 0-05) highergrades
of CCM than expected, but the difference
between observed and expected was much
less than for rats treated with fraction
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TABLE III. Relation of C(RD, (1-CM and Sq.M to SWS Mouse Skin Effective
Dose U)Jnits (SMED)
Treatmenit by iintratiracheal
Groups instillation (±- V7P)
27+ 28 None
25+ 26 Atropiine and anaesthetic
1+4 SWS
2+5 SWS
7+10 Fractioni G
3+ 6 SWS
8+ 11 Fraction G
9+12 Fraction G
13+16 Fraction P(SG)
19+22 Fraction (R+P)G
14+17 Fractioni P(SG)
20+ 2'3 Fraction (R+P)G
15+ 18 Fraction P(SG)
21+ 24 Fraction (R+P')G
All grouips given low doses of SWS
or fractions
All groups givein intermediate doses
of SWS or fractions
All groups given high doses of SWS
No. of rats Actual (lose
examined given each
I post treatment
mortem (mg)
34 0
:34 0
23 l1
22 22
24 11
22 44
24 22
23 44
24 7-5
2:3 12
22 15
23 24
22 30
24 48
Ratio of mean grade (0)/mcan
SMED
(11 mg)
0
1
2
32-
4
6*4
12 8
15-2
26 5
30 .'3
52 9
60 6
105.9
CRD
0 85
0 90
0 91
1 07
0-92
0 97
1 02
1 -04
0 97
0 94
1 19
1 -04
1 21
1*11
grade (E)
CCML
0-26
0-24
0 54
0-89
0 70
0 54
1 68
1 70
1- 27
1 05
1 36
1 79
1 4.49
2 01
Sq.Al
0 52
0-08
0 40
1 *33
0-13
0-42
1 -02
1l 53
0 13
0 90
1 40
1 -76
2 49
2 82
0 93 0 89 0 39 94
91
91,
107 1 48 1 39
1 08 15.8 1 82
(R + P)G A VP (Groups 19-24 combined)
(P < 0.001). Rats treated with SWS at
any level A VP (Groups 1-6 combined)
had higher grades of CCM than control
rats (P < 0.01), but far lower grades than
rats treated with any of the fractions
(P < 0.001).
If it had not been for the high grades
of CCM in Groups 23 and 24, the results as
a whole would have suggested that
exposure to AVP did not increase the CCM
grade in animals treated with SWS or its
fractions by repeated intratrachealinstilla-
tion.
Effect ofexposure to VP and other treatmients
on the incidence and severity of Sq.l
(Table II)
Exposure to VP (Group 27) was
associated with a slight and insignificant
increase in the incidence of Sq.M com-
pared with no treatment (Group 28) (3 out
of 18 rats compared with 1 out of 16 rats
examined post mortem).
Only in 2 groups (Groups 23 and 24)
did the number of rats with Sq.M
significantly exceed the expected nuimber
based on the incidence of Sq.MI in all rats
in the experiment that were examined
post-mortem (P < 0-001 and P < 0-01
respectively). The differences were re-
flected as significantly higher than ex-
pected mean grades for Sq.M (P < 0 05
and P < 0-001 respectively).
A Friedman non-parametric analysis
of variance of ratio of observed mean
grade to expected mean grade of Sq.M
was carried out for groups I to 24 and the
results showed: (1) a highly significant
increase with dose level ofSWS or fraction
(P < 0.001). On average, the ratio in-
creased by 4 7 times from the lowest to
the highest dose levels; (2) a significantly
higher ratio for fraction (R + P)G than
for the other treatments (P < 0.01); (3)
no effect of vapour phase. In 5 out of the
12 comparisons between otherwise com-
parable groups VP gave a higher ratio and
in the other 7 a lower one.
Neoplasms
At post mortem no rat in any group
was found to have a neoplasm of any kind
in the lung. When compared by the
method described in Davis et al. (1975b)
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differences between the groups in the
incidence of extrapulmonary neoplasms
were no more than might have been ex-
pected bv chance.
Relation between occtrrence of CR!), CC-1(
and Sq.J
As is apparent from Table III, in-
creasing dose of SWS or its fractions was
significantly associated with all 3 types of
lesion CRD, CCM and Sq.M. However,
treatment with fraction P(SG) was more
strongly associated with higher mean
CRD grade than with higher mean
CCM or Sq.M grades. Treatment with
fraction (R + P)GC on the other hand, was
more strongly associated with higher
mean grades of CCiM and Sq.M than with
higher mean CRD grade.
No systematic attempt was made in
this experiment to examine the relation-
ship between CRD, CCM and Sq.M
grades in individual rats (see Davis et al.,
1975c). However, a significant positive
correlation (r 0 43, P < 0.05) was found
between the ratio O/E for CCM and that
for Sq.M in the 24 treated groups.
D)ISCUSSION
Exposure to VP alone did not inerease
the incidence of CRD, CCM or Sq.M and
its apparent effects on body weight and
survival are similar to those associated
with sham exposure (Davis et al., 1975c).
VP did not increase the incidence of CRD,
CCM or Sq.M in rats also exposed to
SWS, or its fractions, by intratracheal
instillation. An exception to this general
statement, however, was encountered in
the case of fraction (R + P)G. Signi-
ficantly higher than expected mean grades
for CCM and Sq.M were seen in rats given
the intermediate and high doses of this
fraction plus ATP, but not in rats similarly
treated without V'P. In so far as this
finding is out of line with the general drift
ofthe results ofthe experiment as a whole,
it should be accepted and interpreted only
with caution.
More convincing, however, are the
clear associations between dose of SWS or
its fractions and CRD, CCM and Sq.M.
The relationship between these three
kinds of lesion are discuissed elsewhere
(Davis et al., 1975c).
Theresultsprovide convincingevidence
that, under the conditions of the experi-
ment, exposure to VP did not increase the
incidence of any kind of neoplasm at any
body site.
In another experiment, Davis et al.
(1975c) exposed rats to unfiltered smoke.
All rats dying after 40 weeks had collec-
tions of macrophages laden with golden
brown pigment (GBM) and there was a
marked increase in CCM and a smaller
increase in Sq.M compared with untreated
controls. In the present experiment no
GBM were seen in V'P exposed rats and the
incidence of CCM and Sq.M did not differ
from that in the controls. This suggests
strongly that GBM and CCM, and possibly
Sq.M also, are reactions to particulate
matter in the smoke.
It is of interest to compare the
response ofrats tointratrachealinstillation
of SWS, fraction (G), P(SG) or (R + P)G
with that of mice exposed to the same
materials by repeated application to the
skin. In order to relate the effects
observed in the lungs in the present
experiment to the tumorigenic activity in
mouse skiii (Rothwell and Whitehead,
personal communication), it is convenient
to represent the dose levels applied by
intratracheal instillation as " SWS mouse-
skin effective dose units " (SMED). This
is defined as the product of the equivalent
dose offraction and the ratio ofthe dose of
SWS to the same dose of fraction to
produce the same mouse skin tumour
yield. If mouse skin tumorigenic activity
paralleled a response in the lungs, then
one would expect the responses to increase
as SMED increased.
Table III relates CRD, CCM and
Sq.M to SMED (given in units of 11 mg
for convenience). The results for the 3
types of lesion are presented as the ratio
of observed mean grade to expected mean
grade, and are simplified by summing over
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the corresponding groups, with and with-
out VP.
There appears to be no relationship at
all between CRD and mouse skin activity
as measured by SMED, but some indica-
tion that the level of CRD depends on the
physical size of the dose given.
For both CCM and Sq.M the evidence
leads to a rather different conclusion.
Considering the dose levels taken together,
the ratios for Sq.M lie in the order
SWS < fraction G < fraction P(SG) <
fraction (R + P)G. However, considering
the dose levels taken separately, there are
considerable discrepancies in the expected
relationship between SMED and the ratio
of either CCM or Sq.M. For instance,
22 mg of SWS produces a higher Sq.M
ratio than 7 5 mg of fraction P(SG),
despite having less than one-seventh in
weight of mouse skin active components,
and 22 mg of fraction G produces a
similar CCM ratio to 24 mg of fraction
(R + P)G, having only aboutt one-tenth
of the active components.
The increase in ratio of either CCM or
Sq.M with increasing SMED for equal
actual dose of the 4 treatments is far less
marked than the increase in ratio with
increasing actual dose of any partictular
treatment. This suggests the magnitude
of the ratio for either lesion is largely
determined by the amount of material
instilled into the trachea an(1 only to a
small extent by differences in specific
mouse skin tumorigenicity.
It is clear that the parallels between
skin tumorigenicity in mice and CCM or
Sq.M in rats are not very close. It seems
possible that, in intratracheal instillation
experiments, CCM and Sq.M, besides
being to some extent indicators of specific
tumorigenicity, are also to a greater degree
indicators ofa reaction not associated with
tumorigenicity.
More detailed tabulations ofthe results
described in this paper can be obtained on
request from P. N. Lee.
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anid Mrs C. Hemming who performed
many of the intracheal instillations and
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husbandry, Mr T. Smith who was respon-
sible for the preparation of the smoke
condensates and fractions and also Mrs
E. A. McFarlane for assistance with the
organization and collection together of
the data from the experiments.
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